Nektar Therapeutics
NKTR
NKTR
279 hedge funds and large institutions have $3.79B invested in Nektar Therapeutics in 2019 Q4 according to their latest regulatory filings, with 61 funds opening new positions, 89 increasing their positions, 95 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
6% less repeat investments, than reductions
Existing positions increased: 89 | Existing positions reduced: 95
2% less funds holding
Funds holding: 286 → 279 (-7)
16% less call options, than puts
Call options by funds: $36.1M | Put options by funds: $42.8M
Holders
279
Holding in Top 10
2
Calls
$36.1M
Puts
$42.8M
Top Buyers
| 1 | +$105M | |
| 2 | +$70M | |
| 3 | +$39M | |
| 4 |
Primecap Management
Pasadena,
California
|
+$20.7M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$16.2M |
Top Sellers
| 1 | -$65.1M | |
| 2 | -$61.9M | |
| 3 | -$38.7M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$36.1M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$16.7M |